|
1
|
Lai KN, Tang SC, Schena FP, Novak J,
Tomino Y, Fogo AB and Glassock RJ: IgA nephropathy. Nat Rev Dis
Primers. 2:33782016. View Article : Google Scholar
|
|
2
|
Suzuki H, Kiryluk K, Novak J, Moldoveanu
Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG
and Julian BA: The pathophysiology of IgA nephropathy. J Am Soc
Nephrol. 22:1795–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schena FP and Cox SN: Biomarkers and
precision medicine in IgA nephropathy. Semin Nephrol. 38:521–530.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szeto CC and Li PK: MicroRNAs in IgA
nephropathy. Nat Rev Nephrol. 10:249–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang G, Kwan BC, Lai FM, Choi PC, Chow KM,
Li PK and Szeto CC: Intrarenal expression of microRNAs in patients
with IgA nephropathy. Lab Invest. 90:98–103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang G, Kwan BC, Lai FM, Chow KM, Li PK
and Szeto CC: Elevated levels of miR-146a and miR-155 in kidney
biopsy and urine from patients with IgA nephropathy. Dis Markers.
30:171–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serino G, Sallustio F, Cox SN, Pesce F and
Schena FP: Abnormal miR-148b expression promotes aberrant
glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol.
23:814–824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Serino G, Sallustio F, Curci C, Cox SN,
Pesce F, De Palma G and Schena FP: Role of let-7b in the regulation
of N-acetylgalactosaminyltransferase 2 in IgA nephropathy. Nephrol
Dial Transplant. 30:1132–1139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serino G, Pesce F, Sallustio F, De Palma
G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, et al: In a
retrospective international study, circulating miR-148b and let-7b
were found to be serum markers for detecting primary IgA
nephropathy. Kidney Int. 89:683–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu S, Bao H, Xu X, Zhou X, Qin W, Zeng C
and Liu Z: Increased miR-374b promotes cell proliferation and the
production of aberrant glycosylated IgA1 in B cells of IgA
nephropathy. FEBS Lett 589B. B4019–B4025. 2015. View Article : Google Scholar
|
|
13
|
Yano N, Endoh M, Miyazaki M, Yamauchi F,
Nomoto Y and Sakai H: Altered production of IgE and IgA induced by
IL-4 in peripheral blood mononuclear cells from patients with IgA
nephropathy. Clin Exp Immunol. 88:295–300. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozomara A, Birgaoanu M and
Griffiths-Jones S: miRBase: From microRNA sequences to function.
Nucleic Acids Res. 47:D155–D162. 2018. View Article : Google Scholar
|
|
15
|
Sai Lakshmi S and Agrawal S: piRNABank: A
web resource on classified and clustered Piwi-interacting RNAs.
Nucleic Acids Res. 36:D173–D177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalvari I, Argasinska J, Quinones-Olvera
N, Nawrocki EP, Rivas E, Eddy SR, Bateman A, Finn RD and Petrov AI:
Rfam 13.0: Shifting to a genome-centric resource for non-coding RNA
families. Nucleic Acids Res. 46:D335–D342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
The Gene Ontology Consortium, . The gene
ontology resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sticht C, De La Torre C, Parveen A and
Gretz N: miRWalk: An online resource for prediction of microRNA
binding sites. PLoS One. 13:e02062392018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
22
|
Wang X: miRDB: A microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakamura T, Ebihara I, Takasaki Y, Tomino
Y and Koide H: Increased expression of proliferating cell nuclear
antigen mRNA in peripheral blood mononuclear cells from patients
with IgA nephropathy. Am J Med Sci. 302:214–219. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang H, Gong F, Zhang S, Zhang CY, Zen K
and Chen X: The origin, function, and diagnostic potential of
extracellular microRNAs in human body fluids. Wiley Interdiscip Rev
RNA. 5:285–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Chen J and Sen S: MicroRNA as
biomarkers and diagnostics. J Cell Physiol. 231:25–30. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan K, Chen J, Li W, Chen Y, Sui W, Zhang
Y and Dai Y: Genome-wide analysis of microRNAs expression profiling
in patients with primary IgA nephropathy. Genome. 56:161–169. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang
T, Cheng W, Zhu J, Shan X, Huang Z, et al: Plasma microRNA
signature of patients with IgA nephropathy. Gene. 649:80–86. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu ZM, Zheng HY, Chen LH, Li YL, Wang Q,
Liao CF and Li XW: Low expression of miR-203 promoted diabetic
nephropathy via increasing TLR4. Eur Rev Med Pharmacol Sci.
22:5627–5634. 2018.PubMed/NCBI
|
|
29
|
Yang X, Wu D, Du H, Nie F, Pang X and Xu
Y: MicroRNA-135a is involved in podocyte injury in a transient
receptor potential channel 1-dependent manner. Int J Mol Med.
40:1511–1519. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cox SN, Sallustio F, Serino G, Pontrelli
P, Verrienti R, Pesce F, Torres DD, Ancona N, Stifanelli P, Zaza G
and Schena FP: Altered modulation of WNT-beta-catenin and PI3K/Akt
pathways in IgA nephropathy. Kidney Int. 78:396–407. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin TJ, Yang SS, Hua KF, Tsai YL, Lin SH
and Ka SM: SPAK plays a pathogenic role in IgA nephropathy through
the activation of NF-κB/MAPKs signaling pathway. Free Radic Biol
Med. 99:214–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Jiang F, Song H, Li X, Xian J and
Gu X: MicroRNA-200a-3p suppresses tumor proliferation and induces
apoptosis by targeting SPAG9 in renal cell carcinoma. Biochem
Biophys Res Commun. 470:620–626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Z, Zhao Z, Yang Y, Luo M, Zhang M,
Wang X, Liu L, Hou N, Guo Q, Song T, et al: MiR-99b-5p and
miR-203a-3p function as tumor suppressors by targeting IGF-1R in
gastric cancer. Sci Rep. 8:101192018. View Article : Google Scholar : PubMed/NCBI
|
